Give unclear details a pause.

FDA is short for US Food and Drug Administration; this agency reviews medicines to decide whether to approve them.

• Does the offer skip a prescription?

  As of September 2026, federal law forbids supplying prescription medicine without a valid prescription.

  Ask how the visit and prescription fit into the offer.

• Is a research product being offered as treatment?

  Some sellers offer weight-loss products for people to use despite a label saying “not for human consumption” or “for research purposes”.

  As of September 2026, the FDA warns of possible harm to health from these products, whose quality is unknown.

  Read what the offer says about the product’s intended use.

• Does a badge stand in for approval?

  A claim of “FDA registered” means the business is recorded with the FDA.

  The National Drug Code, or NDC, identifies a medicine with a number in a drug listing.

  As of September 2026, neither a business’s FDA registration nor a medicine’s National Drug Code (NDC) proves that the medicine has FDA approval.

  Ask about the exact product, rather than a badge on the website.

• Is a made-to-order medicine called approved?

  As of September 2026, a compounded medicine—a medicine made to order—does not have FDA approval.

  Ask for a plain explanation of why a made-to-order medicine is being considered for your needs.

As of September 2026, semaglutide and tirzepatide injections are no longer listed by the FDA as being in short supply nationwide.

Federal law, as of September 2026, restricts repeated or large supplies of made-to-order medicine closely matching medicines people can already buy.

A change for a particular patient can be allowed if the person writing the prescription decides it makes a meaningful difference for that patient.

Charging less, by itself, does not make a copy qualify for that exception.

Ask what change is needed for you and who has recorded that reason.

Storage notes checked in September 2026 depend on the medicine: some peptide medicines need a fridge, while others do not.

Ask the pharmacy to explain the storage directions for the exact medicine it sends.

GLP-1 is a name you may see for some medicines used for weight loss or type 2 diabetes.

It includes semaglutide under the names Ozempic and Wegovy, plus tirzepatide under the names Mounjaro and Zepbound.

As of September 2026, the FDA advises against using GLP-1 injections that arrive warm or have not been kept cool enough.

As of September 2026, reports received by the FDA describe possible errors in the amount used for made-to-order semaglutide injections.

Some of the reported problems needed hospital care.

Ask the pharmacist who supplied the medicine to explain the directions if the label leaves you unsure.